OTCMKTS:NPHC Nutra Pharma (NPHC) Stock Price, News & Analysis $0.0001 0.00 (0.00%) As of 12:47 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartSEC Filings About Nutra Pharma Stock (OTCMKTS:NPHC) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Nutra Pharma alerts:Sign Up Key Stats Today's Range$0.0001▼$0.000150-Day Range N/A52-Week Range$0.0001▼$0.0050Volume125 shsAverage Volume605,736 shsMarket Capitalization$715.97 thousandP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Nutra Pharma Corporation is a biotechnology and pharmaceutical company focused on developing and commercializing products for pain management and related health applications. The company’s research has centered on the use of modified venom-derived compounds, including proteins associated with cobra venom, in non-opioid therapeutic products. Nutra Pharma’s principal branded products have included Nyloxin, an over-the-counter pain-relief product marketed for people, and Pet Pain-Away, a product designed for companion animals. The company has also promoted Equine Pain-Away for horses. These products have been positioned as topical or orally administered alternatives for managing certain types of pain, subject to applicable labeling and regulatory requirements. Nutra Pharma has historically operated in the biotechnology and specialty pharmaceutical sectors, serving consumer and animal-health markets primarily through product sales and distribution arrangements. Publicly available information about its current operations, geographic reach, and leadership is limited and may change over time.AI Generated. May Contain Errors. Read More Receive NPHC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Nutra Pharma and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. NPHC Stock News HeadlinesNutra Pharma Corp.October 23, 2026 | marketwatch.comNutra Pharma Delays Quarterly SEC FilingAugust 14, 2026 | tipranks.comFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each warning issued before the crisis hit. Now the founder of Weiss Ratings, the only conflict-free rating agency in America, says he is watching a $3 trillion problem that could trigger a chain reaction across markets and banks.October 27 at 1:00 AM | Weiss Ratings (Ad)Nutra Pharma Corp. (NPHC)July 2, 2026 | nasdaq.comNutra Pharma Corp (NPHC)April 9, 2025 | uk.investing.comPharmaNutra SpA: Strong Sales Growth and International Expansion Reinforce Buy RatingSeptember 11, 2024 | markets.businessinsider.comNutri Pharmaceuticals Research Inc.October 7, 2023 | barrons.comL-Nutra Reports First-Ever Study Showing ProLon® Improves Skin Health, Happiness, and ConfidenceMarch 1, 2023 | benzinga.comSee More Headlines NPHC Stock Analysis - Frequently Asked Questions How have NPHC shares performed this year? Nutra Pharma's stock was trading at $0.0001 on January 1st, 2026. Since then, NPHC stock has increased by 0.0% and is now trading at $0.0001. How were Nutra Pharma's earnings last quarter? Nutra Pharma Corp. (OTCMKTS:NPHC) released its quarterly earnings data on Friday, August, 17th. The company reported $0.00 earnings per share for the quarter. The firm had revenue of $30 thousand for the quarter. How do I buy shares of Nutra Pharma? Shares of NPHC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Nutra Pharma own? Based on aggregate information from My MarketBeat watchlists, some other companies that Nutra Pharma investors own include Anglo American (AAL), Adobe (ADBE), Automatic Data Processing (ADP), Audioeye (AEYE), Applied Materials (AMAT), Advanced Micro Devices (AMD) and Abtech (ABHD). Company Calendar Last Earnings8/17/2018Today10/27/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Biotechnology Sub-IndustryBiotechnology Current SymbolOTCMKTS:NPHC CIK1119643 Webwww.nutrapharma.com Phone(954) 509-0911Fax877-895-5647Employees6Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$2.05 million Net Margins-2,093.05% Pretax Margin-2,093.05% Return on EquityN/A Return on Assets-317.95% Debt Debt-to-Equity RatioN/A Current Ratio0.02 Quick Ratio0.02 Sales & Book Value Annual Sales$380 thousand Price / Sales1.88 Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares7,159,740,000Free Float2,756,500,000Market Cap$715.97 thousand OptionableNot Optionable Beta1.05 The 7 Hottest IPO Stories of 2026MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.Get This Free Report This page (OTCMKTS:NPHC) was last updated on 10/27/2026 by MarketBeat.com Staff. From Our PartnersU.S. Military Expands Orders for This Drone MakerA Nasdaq-listed drone maker is racking up defense contracts on both sides of the border. The Canadian Armed Fo...The Tomorrow Investor | SponsoredFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | SponsoredThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | SponsoredLast call for your free 0DTE reportThe 0DTE Game Plan lays out a simple 3-step framework for trading same-day options: Plan it, profit from it, p...Profits Run | SponsoredWhy Gerardo Del Real says wait before buying uranium stocksGerardo Del Real is calling it the Third Convergence Event, a new catalyst hitting the uranium market that he ...Digest Publishing | SponsoredFirst Look: Elon’s “Starphone”Rumors are swirling that Elon Musk is developing a new mobile device that could rival the iPhone. It's said to...Stansberry Research | SponsoredHow options let you do more with less capitalWould you rather spend $5,000 buying 100 shares of a $50 stock, or control those same 100 shares for a fractio...Base Camp Trading | SponsoredI've seen this movie before (last time: 17,556%)My track record speaks for itself... KDA: 17,556%. PRE: 3,900%. OCEAN: 2,650%. Every single one was called ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nutra Pharma Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nutra Pharma With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
